Contact this trialFirst, we need to learn more about you.
Coagulation Factor Replacement Therapy
Wilate for Von Willebrand Disease
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing a new treatment for heavy menstrual bleeding in women with von Willebrand disease. It will last for 2 years and involve multiple centers. The study will help determine if the treatment
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service